Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2025-12-25 @ 12:31 AM
NCT ID:
NCT06273267
Eligibility Criteria:
Inclusion Criteria:
* Patients aged 0 to 25
* Follow-ups at APHP
* Supported by a palliative care team from Ile de France (Robert-Debré hospital, Necker hospital or Paliped-Île-de-France Regional Pediatric Palliative Care Resource Team) between January 2020 and December 2022
* Suffering from a serious non-progressive neurological disease (ACT-4)
* Information and absence of opposition from the holders of parental authority of the minor patient and the guardian or curator of the adult patient if he is under guardianship/curatorship;
Exclusion Criteria:
* Other ACT category (1, 2, 3 or 5) of the classification of diseases by the Association for Children's Palliative Care (ACT) and the Royal College of Paediatrics and Child Health (RCPCH) during treatment
* Patients for whom there was no pediatric palliative care intervention
* Patients in palliative care without follow-up at the APHP
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
25 Years
Study:
NCT06273267
Study Brief:
Protocol Section:
NCT06273267